Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and Th1/Th2 immune imbalance in polycystic ovary syndrome
ChiCTR2300078999Phase 4Not yet recruiting
- Sponsor
- The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of metformin in polycystic ovary syndrome (PCOS), sponsored by The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University. Primary endpoints: Related cytokine levels and Th1/Th2 ratio, Fasting plasma glucose and 2 more. Planned start Dec 2023; status: not yet recruiting.
02
Drugs
metformin
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on ChiCTR2300078999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078999.